Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.

The Trust Hospital has called for better access to inhale medications for asthma patients in Ghana. Dr. Juliana Oye Ameh, ...

When Stephen Wright asked AI which UK shares he should take a look at, the number one choice is a stock that wasn’t even on ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

Former Sanofi subsidiary Zentiva has signed off on up to 220 million euros for the rights to commercialize and manufacture an ...

Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A ...

Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has ...

AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its ...

The AstraZeneca PLC ADR AZN rallied 1.28% to $69.69 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.02% to ...